1 / 13

dm+d Implementation &

dm+d Implementation &. Andrew Frangleton, Product Development Director. What is the Multilex Drug Data File?. Drug Terminology and attributes Products, packs prices, re-imbursement information etc Clinical Decisions Support Drug-Drug Interactions Allergy Check Contra Indications etc

maegan
Télécharger la présentation

dm+d Implementation &

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. dm+d Implementation& Andrew Frangleton, Product Development Director

  2. What is the Multilex Drug Data File? • Drug Terminology and attributes • Products, packs prices, re-imbursement information etc • Clinical Decisions Support • Drug-Drug Interactions • Allergy Check • Contra Indications • etc • Referential information • Monographs • Non active decision support information • External Links • BNF, SPc • PIL • etc

  3. FDBE’s Business Partners include

  4. Status of Multilex to dm+d Mapping • Overview of FDBE’s internal mapping project • VMP/VMPP maps (70%) • AMP/AMPP maps (48%) • Appliances and VTM – map problems • Issues holding up progress • Similar but different Models • Model Population and stability • V2 Model released April 2004 • VTM not populated • Secondary Care products due later this year

  5. Differences between Multilex & dm+d • Examples • VTM & Product SetMultilex ‘branded’ Product Sets have no equivalence • dm+d has package information in product descriptionseg. injection ampoules, powder sachets • Multilex is more granulareg. Modified Release preparations • Difference in coverage

  6. Working Together • Harmonisation • Striving to reach an agreed way forward • Can improve on the 80% currently not mapped • Involvement of current users is important • Agreement to provide early access to dm+d content by FDBE • Agreement to deliver dm+d as part of the FDBE Product • Agreement to deliver FDBE standard product through national distribution process • FDBE Implementation Team are available to help with dm+d integration

  7. Implementation Services Core services • Technical & functional skills • Comprehensive documentation • Training and consultancy services • Implementation Review – ensuring the quality of final implementation • Post-implementation support services to integrate new features

  8. Delivery of MDDF and dm+d - Today • Current Deliverable Options • ASCII • Link tables provided to allow access to dm+d identifiers • Toolkit • API Functions provided to allow access to dm+d identifiers • Health Warning - link is less than 100%

  9. Future Implementation • Next Toolkit Release will include: • Drug Navigation functions utilising dm+d in conjunction with Multilex • Native instantiation of Drug Object for dm+d codes • Native calls to Decision Support for dm+d codes • SNOMED-CT enabled Decision Support

  10. BT Syntegra – CSA • Working together on Drug Decision Support Service • Will use dm+d to drive product selection • Decision Support will use SNOMED-CT inputs

  11. Summary… • Linking of Multilex to dm+d in progress • Software API’s and ASCII data suitable for linking - available now with limited dataset • Revised API’s due later this year giving a more integrated approach • Customer Implementation Services are availableto help LSP implementations

More Related